Previous studies conducted to evaluate the best time point for blood sampling after GnRH agonist application in populations other than Korean used different doses of GnRH agonist, limited numbers of male subjects, different LH cut-off values, and different analytical platforms to diagnose CPP [6,17,18,19]. The gene discussed is GNRH1; the disease is central precocious puberty.